Tower Research Capital LLC (TRC) - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 56 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$10,000
+11.1%
46,511
+21.8%
0.00%
Q2 2022$9,0000.0%38,187
+19.7%
0.00%
Q1 2022$9,000
+28.6%
31,912
+157.0%
0.00%
Q4 2021$7,000
+600.0%
12,418
+1203.0%
0.00%
Q2 2021$1,000
-91.7%
953
-86.6%
0.00%
Q1 2021$12,000
-57.1%
7,110
-69.0%
0.00%
-100.0%
Q4 2020$28,000
-78.3%
22,937
-74.7%
0.00%0.0%
Q3 2020$129,000
+200.0%
90,681
+157.2%
0.00%
-50.0%
Q2 2020$43,000
+760.0%
35,253
+774.8%
0.00%
Q1 2020$5,000
-16.7%
4,030
+51.4%
0.00%
Q4 2019$6,000
-53.8%
2,661
-54.4%
0.00%
-100.0%
Q3 2019$13,000
+85.7%
5,834
+124.5%
0.00%
Q2 2019$7,000
-30.0%
2,599
-5.0%
0.00%
-100.0%
Q1 2019$10,000
-16.7%
2,735
-47.2%
0.00%0.0%
Q4 2018$12,000
+200.0%
5,181
+196.4%
0.00%
Q2 2017$4,000
-80.0%
1,748
-71.1%
0.00%
-100.0%
Q1 2017$20,000
+566.7%
6,044
+391.8%
0.00%
Q2 2016$3,000
-75.0%
1,229
-67.1%
0.00%
-100.0%
Q1 2016$12,000
+140.0%
3,731
+131.3%
0.00%
Q3 2015$5,000
-16.7%
1,613
-4.7%
0.00%
-100.0%
Q1 2015$6,000
-33.3%
1,692
+22.5%
0.00%0.0%
Q4 2014$9,000
-83.0%
1,381
-85.6%
0.00%
-83.3%
Q3 2014$53,000
-39.8%
9,606
+31.2%
0.01%
-45.5%
Q1 2014$88,000
+100.0%
7,322
+79.5%
0.01%
+120.0%
Q3 2013$44,000
+18.9%
4,080
+2.7%
0.01%
+66.7%
Q2 2013$37,0003,9720.00%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Perceptive Advisors 6,574,060$27,874,0001.68%
SENZAR ASSET MANAGEMENT, LLC 798,381$3,385,0000.58%
Cormorant Asset Management, LP 850,000$3,604,0000.48%
Palo Alto Investors LP 2,135,739$9,056,0000.40%
Opus Point Partners Management, LLC 99,959$424,0000.34%
Granahan Investment Management 1,582,237$6,709,0000.19%
Joel Isaacson & Co., LLC 70,660$300,0000.08%
MARINER INVESTMENT GROUP LLC 59,700$253,0000.06%
MYCIO WEALTH PARTNERS, LLC 75,000$318,0000.06%
Cornerstone Capital, Inc. 59,200$251,0000.06%
View complete list of ACELRX PHARMACEUTICALS INC shareholders